FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893988790> ?p ?o ?g. }

• W2893988790 endingPage "1141" @default.
• W2893988790 startingPage "1133" @default.
• W2893988790 abstract "Abstract Background: Adolescents and young adults (AYA: 15–39 years) with acute lymphoblastic leukemia (ALL) have inferior survival when compared with children (1–14 years). An approach is lacking that includes both patients enrolled and not enrolled in clinical trials, and includes the contribution of health care delivery, treatment, and clinical prognosticators. Methods: We assembled a retrospective cohort of ALL patients diagnosed between 1–39 years (AYA: n = 93; child: n = 91) and treated at a single institution between 1990 and 2010, irrespective of clinical trial enrollment. We modeled relapse risk (i) during therapy and (ii) after completing therapy. Results: On-therapy relapse: AYA experienced an increased risk of on-therapy relapse versus children (HR, 10.5; P = 0.004). In multivariable analysis restricted to AYA, independent predictors of relapse included lack of clinical trial enrollment (HR, 2.6, P = 0.04) and nonwhite race/ethnicity (HR, 2.2; P = 0.05). Relapse after completing therapy: When compared with children, AYA experienced an increased risk of relapse after completing therapy (HR, 7.7; P &lt; 0.001). In multivariable analysis restricted to AYA, longer therapy (months of maintenance: HR, 0.7; P &lt; 0.001; months of consolidation: HR, 0.8; P = 0.03) protected against relapse. Conclusions: Among AYA, aspects of health care delivery (clinical trial enrollment, nonwhite race/ethnicity) are associated with relapse during therapy, and aspects of treatment (shorter duration of maintenance and consolidation) are associated with relapse after completing therapy. Impact: These findings highlight the importance of clinical trial enrollment and therapy duration (maintenance, consolidation) in ensuring durable remissions in AYA ALL. Future studies encompassing health care delivery, treatment, and biology are needed. Cancer Epidemiol Biomarkers Prev; 27(10); 1133–41. ©2018 AACR." @default.
• W2893988790 created "2018-10-05" @default.
• W2893988790 creator A5003401361 @default.
• W2893988790 creator A5004337476 @default.
• W2893988790 creator A5022033181 @default.
• W2893988790 creator A5024093017 @default.
• W2893988790 creator A5039755806 @default.
• W2893988790 creator A5043738456 @default.
• W2893988790 creator A5058365130 @default.
• W2893988790 creator A5067398740 @default.
• W2893988790 date "2018-10-01" @default.
• W2893988790 modified "2023-10-17" @default.
• W2893988790 title "Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment" @default.
• W2893988790 cites W1576736872 @default.
• W2893988790 cites W1801876107 @default.
• W2893988790 cites W1904414599 @default.
• W2893988790 cites W1977546984 @default.
• W2893988790 cites W1993312424 @default.
• W2893988790 cites W2002526138 @default.
• W2893988790 cites W2010729137 @default.
• W2893988790 cites W2016833582 @default.
• W2893988790 cites W2030049579 @default.
• W2893988790 cites W2043587224 @default.
• W2893988790 cites W2060343635 @default.
• W2893988790 cites W2061266683 @default.
• W2893988790 cites W2103564256 @default.
• W2893988790 cites W2129291628 @default.
• W2893988790 cites W2131397497 @default.
• W2893988790 cites W2134118606 @default.
• W2893988790 cites W2139223948 @default.
• W2893988790 cites W2146762986 @default.
• W2893988790 cites W2157249349 @default.
• W2893988790 cites W2259143846 @default.
• W2893988790 cites W2274561055 @default.
• W2893988790 cites W2407107555 @default.
• W2893988790 cites W2589090458 @default.
• W2893988790 cites W2592474808 @default.
• W2893988790 cites W2614832345 @default.
• W2893988790 cites W2788285407 @default.
• W2893988790 cites W4240338964 @default.
• W2893988790 doi "https://doi.org/10.1158/1055-9965.epi-18-0430" @default.
• W2893988790 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6238217" @default.
• W2893988790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30262597" @default.
• W2893988790 hasPublicationYear "2018" @default.
• W2893988790 type Work @default.
• W2893988790 sameAs 2893988790 @default.
• W2893988790 citedByCount "13" @default.
• W2893988790 countsByYear W28939887902018 @default.
• W2893988790 countsByYear W28939887902019 @default.
• W2893988790 countsByYear W28939887902020 @default.
• W2893988790 countsByYear W28939887902021 @default.
• W2893988790 countsByYear W28939887902022 @default.
• W2893988790 countsByYear W28939887902023 @default.
• W2893988790 crossrefType "journal-article" @default.
• W2893988790 hasAuthorship W2893988790A5003401361 @default.
• W2893988790 hasAuthorship W2893988790A5004337476 @default.
• W2893988790 hasAuthorship W2893988790A5022033181 @default.
• W2893988790 hasAuthorship W2893988790A5024093017 @default.
• W2893988790 hasAuthorship W2893988790A5039755806 @default.
• W2893988790 hasAuthorship W2893988790A5043738456 @default.
• W2893988790 hasAuthorship W2893988790A5058365130 @default.
• W2893988790 hasAuthorship W2893988790A5067398740 @default.
• W2893988790 hasBestOaLocation W28939887901 @default.
• W2893988790 hasConcept C126322002 @default.
• W2893988790 hasConcept C137403100 @default.
• W2893988790 hasConcept C144024400 @default.
• W2893988790 hasConcept C168563851 @default.
• W2893988790 hasConcept C187212893 @default.
• W2893988790 hasConcept C19165224 @default.
• W2893988790 hasConcept C205545832 @default.
• W2893988790 hasConcept C2778461978 @default.
• W2893988790 hasConcept C2909962599 @default.
• W2893988790 hasConcept C535046627 @default.
• W2893988790 hasConcept C71924100 @default.
• W2893988790 hasConcept C72563966 @default.
• W2893988790 hasConceptScore W2893988790C126322002 @default.
• W2893988790 hasConceptScore W2893988790C137403100 @default.
• W2893988790 hasConceptScore W2893988790C144024400 @default.
• W2893988790 hasConceptScore W2893988790C168563851 @default.
• W2893988790 hasConceptScore W2893988790C187212893 @default.
• W2893988790 hasConceptScore W2893988790C19165224 @default.
• W2893988790 hasConceptScore W2893988790C205545832 @default.
• W2893988790 hasConceptScore W2893988790C2778461978 @default.
• W2893988790 hasConceptScore W2893988790C2909962599 @default.
• W2893988790 hasConceptScore W2893988790C535046627 @default.
• W2893988790 hasConceptScore W2893988790C71924100 @default.
• W2893988790 hasConceptScore W2893988790C72563966 @default.
• W2893988790 hasFunder F4320332161 @default.
• W2893988790 hasFunder F4320337351 @default.
• W2893988790 hasIssue "10" @default.
• W2893988790 hasLocation W28939887901 @default.
• W2893988790 hasLocation W28939887902 @default.
• W2893988790 hasLocation W28939887903 @default.
• W2893988790 hasLocation W28939887904 @default.
• W2893988790 hasOpenAccess W2893988790 @default.
• W2893988790 hasPrimaryLocation W28939887901 @default.
• W2893988790 hasRelatedWork W2315085516 @default.
• W2893988790 hasRelatedWork W2407161884 @default.

• next